The role of chemotherapy for advanced oro and hypopharyngeal cancer

Auris Nasus Larynx

Volumn 31, Issue 2, 2004, Pages 113-118

  Kohno, Naoyuki ^a  

^a KYORIN UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Concurrent chemoradiotherapy; Hypopharynx; Oropharynx; Stomatitis

Indexed keywords

AMIFOSTINE; ANTINEOPLASTIC AGENT; COLONY STIMULATING FACTOR; PILOCARPINE; SCAVENGER;

ADVANCED CANCER; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL TRIAL; DRUG EFFECT; DRUG EFFICACY; HUMAN; HYPOPHARYNX CARCINOMA; LYMPHADENECTOMY; META ANALYSIS; OROPHARYNX CARCINOMA; PATIENT COMPLIANCE; REVIEW; STOMATITIS; TREATMENT INDICATION;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; HUMANS; HYPOPHARYNGEAL NEOPLASMS; META-ANALYSIS; OROPHARYNGEAL NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE;

EID: 2342472685     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anl.2004.02.001     Document Type: Review

References (35)

1. Strong E.W. Site of treatment failure of head and neck cancer. Cancer Treat. Symp. 2:1983;15-20
2. Vikram B., Strong E.W., Shah J., Spiro R. Failure at the primary site following multi-modality treatment for advanced head and neck cancer. Head Neck Surg. 6:1984;720-723
3. Hong W.K., Bromer R. Current concepts: chemotherapy in head and neck cancer. New Engl. J. Med. 308:1983;75-79
4. Kramer S., Gelber R.D., Snow J.B., Marcial V.A., Lowry L.D., Dawis L.W., et al. Combined radiation therapy and surgery in the management of advanced head and neck cancer: final report of study 73-03 of the Radiation Therapy Oncology Group. Head Neck Surg. 10:1987;19-30
5. Marcial V.A., Pajak T.F., Chang C., Tupchong L., Setz J. Hyperfractionated photon radiation therapy in the treatment of advanced squamous cell carcinoma of the oral cavity pharynx, larynx, and sinuses, using radiation therapy as the only modality: (preliminary report) by the Radiation Therapy Oncology Group (RTOG). Int. J. Radiat. Oncol. Biol. Phys. 13:1987;41-47
6. Machtay M., Rosenthal D.I., Hershock D., Jones H., Williamson S., Greenberg M.J., et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced respectable oropharyngeal carcinoma; a University of Pennsylvania phase II trial. J. Clin. Oncol. 20:2002;3964-3971
7. Chang T.M. Induction chemotherapy for advanced head and neck cance: a literature review. Head Neck Surg. 10:1988;150-159
8. Hong W.K. Induction chemotherapy for advanced head and neck cancer. Head Neck Surg. 10:1988;147-149
9. Liu P.Y., Dahlberg S., Crowley J. Selection designs for pilot studies based on survival. Biometrics. 49:1983;391-398
10. Schuller D.E., Metch B., Stein D.W., Mattox D., Mccracken J.D. Preoperative chemotherapy in advanced respectable head and neck cancer. Final report of the southwest oncology group. Laryngoscope. 98:1988;1205-1211
11. Dinges S., Budach V., Stuschke M., Budach W., Boehmer D., Schrader M., et al. Chemo-radiotherapy for locally advanced head and neck cancer-long term results of a phase II trial. Eur. J. Cancer. 7:1997;1152-1155
12. Dimery I.W., Kramer A.M., Choksi A.J., Hong W.K. Neoadjuvant chemotherapy and radiotherapy in larynx preservation. Am. J. Clin. Oncol. 12:1989;173-177
13. Brasnu D., Fabre A., Menard M., Basst V., Janot F., Lacconrreje H. Analysis of survival after induction chemotherapy in pyriform sinus carcinoma. Head Neck Surg. 10:1988;396-401
14. Lore J.M. Jr., Bonilla J.A., Spoulding M., Lee K.Y., Kaufman S., Sundquist N., et al. Preoperative adjuvant chemotherapy for advanced head and neck cancer. J. Surg. Oncol. Suppl. 1:1989;2-6
15. Vokes E.E., Weichselbaum R.R., Mick R., McEvilly J.M., Haraf D.J., Panje W.R. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. J. Natl. Cancer Inst. 84:1992;877-882
16. Lefebvre J.L., Chevalier D., Luboinski B., Kirkpatrick A., Collette L., Sahmond T. Larynx preservation in pyriform sinus cancer: preliminary results of European Organization for Research and Treatment of Cancer phase III trial. EORTC Head and Neck Cancer Cooperative Group. J. Natl. Cancer Inst. 88:1996;890-899
17. Harari P.M. Why has induction chemotherapy for advanced head and neck cancer become a united states community standard of practice? J. Clin. Oncol. 15:1997;2050-2055
18. Pignon J.P., Bourhis J., Domenge C., Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analysis of updated individual data. Lancet. 358:2000;949-955
19. Munro A.J. An overview of randomized controlled trials of adjuvant chemotherapy in head and neck cancer. Br. J. Cancer. 71:1995;83-91
20. El-Sayed S., Nelson N. Adjuvant and adjunctive chemotherapy in the management of squamous cell carcinoma of the head and neck region: a meta-analysis of prospective and randomized trials. J. Clin. Oncol. 14:1996;838-847
21. Brizel D.M., Alberts M.A., Fisher S.R., Scher R.L., Richtsmeier W.J., Hars V., et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. New Engl. J. Med. 338:1998;1798-1804
22. Eschwege F., Sancho-Garnier H., Gerard J.P., Medelain M., DeSaulty A., Jortay A., et al. Ten-year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinoma of oropharynx: experience of European Organization for Research and Treatment of Cancer. Natl. Cancer Inst. Monogr. 6:1988;275-278
23. Calais G., Alfonsi M., Bardet E., Sire C., Germain T., Bergerot P., et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced stage oropharynx carcinoma. J. Natl. Cancer Inst. 91:1999;2081-2086
24. Jeremic B., Shibamoto Y., Milicic B., Nikolic N., Dagovic A., Aleksandrovic J., et al. Hyperfractionated radiation therapy with or without concurrent low-dose daily cisplatin in locally advanced squamous cell carcinoma of head and neck: a prospective randomized trial. J. Clin. Oncol. 18:2000;1458-1464
25. Taylor S.G. IV, Murthy A.K., Vannetzel J.M., Colin P., Dray M., Caldarelli D.D., et al. Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer. J. Clin. Oncol. 12:1994;385-395
26. Pinnaro P., Cercato M.C., Giannarelli D., Carlini P., Del Vecchio M.R., Ambesi Impiombato F., et al. A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck. Ann. Oncol. 5:1994;513-519
27. Adelstein D.J., Saxton J.P., Lavertu P., Rybicki L.A., Esclamado R.M., Wood B.G., et al. Maximizing local control and organ preservation in stage IV squamous cell head and neck cancer with hyperfractionated radiation and concurrent chemotherapy. J. Clin. Oncol. 20:2002;1405-1410
28. Kies M.S., Haraf D.J., Rosen F., Stenson K., List M., Brockstein B., et al. Intensive combined therapy with CDDP, 5-FU, hydroxyurea and bid radiation (C-FHX) for stage IV squamous cancer(SCC) of the head and neck. Proc. Am. Soc. Clin. Oncol. 15:1996;314
29. Wendt T.G., Grabenbauer G.G., Rodel C.M., Thiel H.-J., Aydin H., Rohloff R., et al. Simultaneous radio-chemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomised multicencer study. J. Clin. Oncol. 16:1998;1318-1324
30. Robbins K.T., Kumar P., Regine W.F., Wong F.S.H., Weir A.B., Flick P., et al. Efficacy of targeted supuradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience. Int. J. Radiat. Oncol. Biol. Phys. 38:2000;263-271
31. Domenge C., Lefebvre J.L., De Raucourt D., Rhein B., Wibault P., Marandas P., et al. Randomized trial of neoadjuvant chemotherapy in oropharyngeal carcinoma. Br. J. Cancer. 83:2000;1594-1598
32. Paccagella A., Orlando A., Marchiori O., Zorat P.L., Cavaniglia G., Sileni V.C., et al. Phase III trial of initial chemotherapy in Stage III or IV head and neck cancers: a study by the Gruppo di Studio sui tumori della Testa e del Collo. J. Natl. Cancer Inst. 86:1994;265-272
33. Giralt J.L., Gonzalez J., del Campo J.M., Maldonado J., Sanz X., Pamias J., et al. Preoperative induction chemotherapy followed by concurrent chemoradiotherapy in advanced carcinoma of the oral and oropharynx. Cancer. 89:2000;939-945
34. Brizel D.M., Wasserman T.H., Henke M., Strnad V., Rudat V., Monnier A., et al. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer. J. Clin. Oncol. 18:2000;3339-3345
35. Kohno N., Kitahara S., Tamura E., Tanabe T. Concurrent chemoradiotherapy with low dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer. Oncology. 63:2002;226-231